Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
23.69
-1.36 (-5.43%)
At close: Jun 5, 2026, 4:00 PM EDT
23.74
+0.05 (0.21%)
After-hours: Jun 5, 2026, 4:16 PM EDT
Mineralys Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Buy Maintains $42 | Buy | Maintains | $42 | +77.29% | May 19, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $48 | Buy | Maintains | $48 | +102.62% | May 19, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 7, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $52 | Buy | Maintains | $52 | +119.50% | May 7, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $54 | Buy | Reiterates | $54 | +127.94% | May 7, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $56 | Buy | Reiterates | $56 | +136.39% | May 7, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 7, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $55 | Buy | Maintains | $55 | +132.17% | Mar 14, 2026 |